Home › NDC Lookup › RxCUI directory › RxCUI 1791229

5 ML diltiazem hydrochloride 5 MG/ML Injection — RxCUI 1791229

Name: 5 ML diltiazem hydrochloride 5 MG/ML Injection (RxCUI 1791229)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1791229 Semantic clinical drug · SCD ● Current RxNorm concept 14 FDA products 17 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1791229

Official name5 ML diltiazem hydrochloride 5 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asdiltiazem hydrochloride 25 MG per 5 ML Injection; dilTIAZem hydrochloride 25 MG in 5 mL Injection

FDA products mapped14

Package NDCs mapped17

Reported Medicaid activity (SDUD)1,055 prescriptions · 15 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Diltiazem: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

The pills and capsules you take by mouth are used for high blood pressure and for chronic stable angina, which is chest pain from the heart's workload. Some capsule brands, such as...
Usually it's taken once a day, and you should swallow it whole. Don't open, chew or crush the capsules. Some products, like DILT-XR, are best taken in the morning on an empty stoma...
How should I take my extended-release capsule or tablet?
The most common ones are a stuffy or runny nose, headache, sore throat, constipation, cough, and swelling in the legs or ankles. Most are mild. Call your doctor if you faint, feel...

📖 Read our full Diltiazem guide →

🕸️ Concept Web — How 5 ML diltiazem hydrochloride 5 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 5 ML diltiazem hydrochloride 5 MG/ML Injection RxCUI 1791229 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Diltiazem 3443 IN
- Diltiazem hydrochloride 203211 PIN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Diltiazem Injection 1791228 SCDF
- Diltiazem hydrochloride Injection 2645898 SCDFP
- Diltiazem Injectable Product 1151887 SCDG
- Diltiazem hydrochloride Injectable Product 2660505 SCDGP
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Diltiazem hydrochloride 5 MG/ML 833194 SCDC

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Diltiazem hydrochloride 5 MG/ML SCDC · 833194
Diltiazem Injection SCDF · 1791228
Diltiazem hydrochloride Injection SCDFP · 2645898
Diltiazem Injectable Product SCDG · 1151887
Diltiazem hydrochloride Injectable Product SCDGP · 2660505

📦 FDA Products & Package NDCs

14 products · 17 package NDCs

17 package NDCs map to RxCUI 1791229 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00641-6013-10	10 VIAL in 1 CARTON (0641-6013-10) / 5 mL in 1 VIAL (0641-6...	Diltiazem Hydrochloride	Hikma Pharmaceuticals USA Inc.	2008-12-17
00641-6014-10	10 VIAL in 1 CARTON (0641-6014-10) / 10 mL in 1 VIAL (0641-...	Diltiazem Hydrochloride	Hikma Pharmaceuticals USA Inc.	2008-12-17
00641-6015-10	10 VIAL in 1 CARTON (0641-6015-10) / 25 mL in 1 VIAL (0641-...	Diltiazem Hydrochloride	Hikma Pharmaceuticals USA Inc.	2008-12-17
00641-9217-10	10 VIAL in 1 CARTON (0641-9217-10) / 5 mL in 1 VIAL (0641-9...	Diltiazem Hydrochloride	Hikma Pharmaceuticals USA Inc.	2008-12-17
00641-9218-10	10 VIAL in 1 CARTON (0641-9218-10) / 10 mL in 1 VIAL (0641-...	Diltiazem Hydrochloride	Hikma Pharmaceuticals USA Inc.	2008-12-17
00641-9219-10	10 VIAL in 1 CARTON (0641-9219-10) / 25 mL in 1 VIAL (0641-...	Diltiazem Hydrochloride	Hikma Pharmaceuticals USA Inc.	2008-12-17
25021-0319-05	10 VIAL in 1 CARTON (25021-319-05) / 5 mL in 1 VIAL	Diltiazem Hydrochloride	Sagent Pharmaceuticals	2024-06-01
25021-0319-10	10 VIAL in 1 CARTON (25021-319-10) / 10 mL in 1 VIAL	Diltiazem Hydrochloride	Sagent Pharmaceuticals	2024-06-01
25021-0319-25	10 VIAL in 1 CARTON (25021-319-25) / 25 mL in 1 VIAL	Diltiazem Hydrochloride	Sagent Pharmaceuticals	2024-06-01
51662-1335-01	5 mL in 1 VIAL (51662-1335-1)	DILTIAZEM HCI	HF Acquisition Co LLC, DBA HealthFirst	2018-12-21
51662-1335-02	1 VIAL in 1 POUCH (51662-1335-2) / 5 mL in 1 VIAL	DILTIAZEM HCI	HF Acquisition Co LLC, DBA HealthFirst	2023-01-19
55150-0425-10	10 VIAL, SINGLE-DOSE in 1 CARTON (55150-425-10) / 5 mL in 1...	DILTIAZEM HYDROCHLORIDE	Eugia US LLC	2023-03-29
55150-0426-10	10 VIAL, SINGLE-DOSE in 1 CARTON (55150-426-10) / 10 mL in...	DILTIAZEM HYDROCHLORIDE	Eugia US LLC	2023-03-29
55150-0427-10	10 VIAL, SINGLE-DOSE in 1 CARTON (55150-427-10) / 25 mL in...	DILTIAZEM HYDROCHLORIDE	Eugia US LLC	2023-03-29
71872-7063-01	1 VIAL in 1 BAG (71872-7063-1) / 5 mL in 1 VIAL	Diltiazem Hydrochloride	Medical Purchasing Solutions, LLC	2020-01-29
71872-7345-01	1 VIAL in 1 BAG (71872-7345-1) / 5 mL in 1 VIAL	Diltiazem Hydrochloride	Medical Purchasing Solutions, LLC	2025-03-12
84549-0319-05	5 mL in 1 VIAL (84549-319-05)	Diltiazem Hydrochloride	ProPharma Distribution	2025-09-18

Observed labelers: Hikma Pharmaceuticals USA Inc. (6) · Eugia US LLC (3) · Sagent Pharmaceuticals (3) · HF Acquisition Co LLC, DBA HealthFirst (2) · Medical Purchasing Solutions, LLC (2) · ProPharma Distribution (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J1163	Inj, diltiazem hcl, 0.5 mg	14	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.